drugset / Trial / NCT01659554
A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to investigate the feasibility, tolerability and safety of surgical debulking and resection with heated intraoperative chemotherapy (HIPEC) followed by repeated intraperitoneal chemotherapy for treatment of recurrent ovarian, primary peritoneal, and fallopian tube carcinomas.
Timeline
- Start
- 2012-03
- Primary completion
- 2014-04
- Completion
- 2014-04
Outcome
Outcome not reported
Stopped: “Principal Investigator left institution”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 75 mg/m2 | Other |
| Subject | Doxorubicin | Other / unclassified | 25 mg | Other |